Amgen "market perform," target price reduced
27.01.09 - Rodman & Renshaw
NEW YORK, January 27 (newratings.com) - Analysts at Rodman & Renshaw reiterate their "market perform" rating on Amgen Inc (AMGN). The target price has been reduced from $80 to $74.
Share Empfehlen Sie diesen Artikel einem Freund!
AMGN zu meinen Aktien hinzufügen und E-Mail Alerts auf Amgen abonnieren
News